 
                        | Product NDC: | 0143-9709 | 
| Proprietary Name: | Milrinone Lactate | 
| Non Proprietary Name: | Milrinone Lactate | 
| Active Ingredient(s): | 20 mg/20mL & nbsp; Milrinone Lactate | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0143-9709 | 
| Labeler Name: | West-ward Pharmaceutical Corp | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077966 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20101203 | 
| Package NDC: | 0143-9709-10 | 
| Package Description: | 20 mL in 1 VIAL (0143-9709-10) | 
| NDC Code | 0143-9709-10 | 
| Proprietary Name | Milrinone Lactate | 
| Package Description | 20 mL in 1 VIAL (0143-9709-10) | 
| Product NDC | 0143-9709 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Milrinone Lactate | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20101203 | 
| Marketing Category Name | ANDA | 
| Labeler Name | West-ward Pharmaceutical Corp | 
| Substance Name | MILRINONE LACTATE | 
| Strength Number | 20 | 
| Strength Unit | mg/20mL | 
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |